Handelsbanken Fonder AB Has $1.18 Million Holdings in Clarivate Plc (NYSE:CLVT)

Handelsbanken Fonder AB raised its stake in shares of Clarivate Plc (NYSE:CLVT) by 103.8% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 127,600 shares of the company’s stock after acquiring an additional 65,000 shares during the quarter. Handelsbanken Fonder AB’s holdings in Clarivate were worth $1,182,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Baupost Group LLC MA bought a new stake in shares of Clarivate during the 3rd quarter worth $150,975,000. River Road Asset Management LLC acquired a new position in Clarivate during the 3rd quarter worth $45,772,000. Clarkston Capital Partners LLC boosted its holdings in Clarivate by 12.0% during the third quarter. Clarkston Capital Partners LLC now owns 57,567,115 shares of the company’s stock valued at $386,275,000 after acquiring an additional 6,172,694 shares during the period. Impactive Capital LP grew its position in shares of Clarivate by 15.7% in the third quarter. Impactive Capital LP now owns 33,108,919 shares of the company’s stock valued at $222,161,000 after purchasing an additional 4,500,000 shares during the last quarter. Finally, Thompson Siegel & Walmsley LLC increased its stake in shares of Clarivate by 40.8% in the third quarter. Thompson Siegel & Walmsley LLC now owns 8,399,229 shares of the company’s stock worth $56,358,000 after purchasing an additional 2,435,239 shares during the period. Institutional investors and hedge funds own 85.72% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. Royal Bank of Canada decreased their target price on Clarivate from $10.00 to $8.00 and set a “sector perform” rating for the company in a research note on Wednesday, February 28th. Morgan Stanley cut their price target on Clarivate from $9.00 to $8.00 and set an “equal weight” rating for the company in a report on Wednesday, February 28th. Oppenheimer cut their target price on shares of Clarivate from $11.00 to $10.00 and set an “outperform” rating for the company in a research note on Wednesday, February 28th. Finally, Barclays dropped their price objective on shares of Clarivate from $7.00 to $6.00 and set an “underweight” rating on the stock in a report on Wednesday, February 28th. Three equities research analysts have rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, Clarivate has a consensus rating of “Hold” and a consensus price target of $8.00.

Clarivate Trading Up 1.7 %

Shares of CLVT stock opened at $7.12 on Monday. The firm has a fifty day moving average of $7.41 and a 200-day moving average of $7.88. The stock has a market cap of $4.76 billion, a price-to-earnings ratio of -4.81, a P/E/G ratio of 1.46 and a beta of 1.24. Clarivate Plc has a 52-week low of $6.07 and a 52-week high of $10.03. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.91 and a current ratio of 0.91.

Clarivate (NYSE:CLVT) last announced its quarterly earnings results on Tuesday, February 27th. The company reported $0.21 EPS for the quarter, hitting analysts’ consensus estimates of $0.21. Clarivate had a negative net margin of 34.66% and a positive return on equity of 9.95%. The firm had revenue of $683.70 million during the quarter, compared to analysts’ expectations of $687.80 million. During the same quarter last year, the company earned $0.20 earnings per share. The company’s revenue for the quarter was up 1.2% compared to the same quarter last year. On average, equities research analysts forecast that Clarivate Plc will post 0.62 earnings per share for the current fiscal year.

Clarivate Company Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.